Bausch Health Cos PE Ratio 2010-2024 | BHC
Current and historical p/e ratio for Bausch Health Cos (BHC) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bausch Health Cos PE ratio as of November 22, 2024 is 2.13.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Bausch Health Cos PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-11-21 |
8.18 |
|
0.00 |
| 2024-09-30 |
8.16 |
$-1.34 |
0.00 |
| 2024-06-30 |
6.97 |
$-1.04 |
0.00 |
| 2023-12-31 |
8.02 |
$-1.62 |
0.00 |
| 2023-09-30 |
8.22 |
$-2.64 |
0.00 |
| 2023-06-30 |
8.00 |
$-1.78 |
0.00 |
| 2023-03-31 |
8.10 |
$-0.75 |
0.00 |
| 2022-12-31 |
6.28 |
$-0.60 |
0.00 |
| 2024-03-31 |
10.61 |
$0.34 |
31.21 |
| 2022-09-30 |
6.89 |
$0.70 |
9.84 |
| 2022-06-30 |
8.36 |
$0.12 |
69.67 |
| 2022-03-31 |
22.85 |
$-1.14 |
0.00 |
| 2021-12-31 |
27.61 |
$-2.66 |
0.00 |
| 2021-09-30 |
27.85 |
$-3.28 |
0.00 |
| 2021-06-30 |
29.32 |
$-3.60 |
0.00 |
| 2021-03-31 |
31.74 |
$-2.86 |
0.00 |
| 2020-12-31 |
20.80 |
$-1.58 |
0.00 |
| 2020-09-30 |
15.54 |
$-5.45 |
0.00 |
| 2020-06-30 |
18.29 |
$-5.79 |
0.00 |
| 2020-03-31 |
15.50 |
$-5.36 |
0.00 |
| 2019-12-31 |
29.92 |
$-5.08 |
0.00 |
| 2019-09-30 |
21.85 |
$-1.76 |
0.00 |
| 2019-06-30 |
25.22 |
$-2.62 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.931B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
